Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 5/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.34 |
| ▸ | ADRA1B | P35368 | 5/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.33 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34469514 | 1.00 | ADRA1D (0.34) | ADRA1DADRA1AADRA1BP2RX7C5AR1 | |
| SCHEMBL3443411 | 0.90 | MAPT (0.32) | ADRA1DADRA1AADRA1BDRD2KCNN4 | |
| SCHEMBL14995111 | 0.88 | P2RX7 (0.34) | ADRA1DADRA1AADRA1BP2RX7C5AR1 | |
| SCHEMBL135939 | 0.85 | MAPT (0.32) | — | |
| SCHEMBL29365624 | 0.85 | MAPT (0.32) | — | |
| Hydrochloric Acid SCHEMBL2833170 | 0.84 | MAPT (0.32) | — | |
| SCHEMBL23781985 | 0.82 | MAPK1 (0.38) | ADRA1DADRA1AADRA1BDRD2 | |
| SCHEMBL17685652 | 0.81 | C5AR1 (0.33) | ADRA1DADRA1AADRA1BC5AR1 | |
| SCHEMBL34469822 | 0.81 | C5AR1 (0.33) | ADRA1DADRA1AADRA1BC5AR1 | |
| SCHEMBL30084634 | 0.81 | ALDH1A1 (0.36) | ADRA1DADRA1AADRA1BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612352-B2 | Process for preparing perfuming intermediate | FIRMENICH SA (CH) | 2026-04-28 | — | — | US | claimed |
| US-20240368068-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATES | FIRMENICH SA (CH) | 2024-11-07 | — | — | US | claimed |
| EP-4367109-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATES | Firmenich SA (CH) | 2024-05-15 | — | — | EP | claimed |
| US-20230095887-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATE | FIRMENICH SA (CH) | 2023-03-30 | — | — | US | claimed |
| WO-2023036732-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATES | FIRMENICH SA (CH) | 2023-03-16 | — | — | WO | claimed |
| WO-2021176009-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATE | FIRMENICH SA (CH) | 2021-09-10 | — | — | WO | claimed |
| EP-3713989-B1 | HIGH MOLECULAR WEIGHT POLYOXYETHYLENE WITH DEEP GLASS TEMPERATURE MADE USING THE GRAFTING THROUGH METHOD | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2021-06-30 | — | — | EP | claimed |
| US-10973847-B2 | Core-to-surface polymerization for the synthesis of star polymers and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-04-13 | — | — | US | claimed |
| US-20200377652-A1 | HIGH MOLECULAR WEIGHT POLYOXYALKYLENE WITH LOW GLASS TRANSITION TEMPERATURE, PRODUCED BY THE GRAFTING THROUGH METHOD | COVESTRO DEUTSCHLAND AG (DE) | 2020-12-03 | — | — | US | claimed |
| EP-3087104-B1 | METHOD FOR CONTROLLED METATHESIS DEPOLYMERIZATION OF NATURAL RUBBER FROM NATURAL RUBBER LATEX | MICHELIN & CIE (FR) | 2019-11-13 | — | — | EP | claimed |
| US-10384987-B2 | 1,3-butadiene synthesis | ARLANXEO DEUTSCHLAND GMBH (DE) | 2019-08-20 | — | — | US | claimed |
| EP-3233768-B1 | 1,3-BUTADIENE SYNTHESIS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2019-02-20 | — | — | EP | claimed |
| US-20170327436-A1 | 1,3-BUTADIENE SYNTHESIS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-11-16 | — | — | US | claimed |
| EP-2897992-B1 | FUNCTIONALIZED RESINS OBTAINED VIA OLEFIN METATHESIS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2017-11-08 | — | — | EP | claimed |
| US-20140088277-A1 | Functionalized Resins Obtained Via Olefin Metathesis | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-03-27 | — | — | US | claimed |
| US-8623962-B2 | Olefin functionalization by metathesis reaction | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-01-07 | — | — | US | claimed |
| US-20130281626-A1 | Polyolefin Compositions and Methods of Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2013-10-24 | — | — | US | claimed |
| US-20120245294-A1 | Olefin Triblock Polymers via Ring-Opening Metathesis Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-09-27 | — | — | US | claimed |
| US-20090318647-A1 | Olefin Functionalization By Metathesis Reaction | EXXONMOBIL CHEMICAL PATENTS INC. | 2009-12-24 | — | — | US | claimed |
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-09-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | SSB, LPXN, LTA | ADRA1D 4361/4885ADRA1A 4511/4885ADRA1B 4017/4885 |
| US-20140088277-A1 | Functionalized Resins Obtained Via Olefin Metathesis | C1R, CBR1, DECR1 | ADRA1D 678/4885ADRA1A 527/4885ADRA1B 936/4885 |
| US-10384987-B2 | 1,3-butadiene synthesis | SQLE, FDFT1, ENO1 | ADRA1D 1129/4885ADRA1A 1381/4885ADRA1B 2009/4885 |
| US-10973847-B2 | Core-to-surface polymerization for the synthesis of star polymers and uses thereof | STARD7, MB, STARD3 | ADRA1D 4830/4885ADRA1A 4418/4885ADRA1B 4742/4885 |
| US-20170327436-A1 | 1,3-BUTADIENE SYNTHESIS | SQLE, FDFT1, ENO1 | ADRA1D 1129/4885ADRA1A 1381/4885ADRA1B 2009/4885 |
| US-12612352-B2 | Process for preparing perfuming intermediate | CBR1, CYP2E1, CBR3 | ADRA1D 681/4885ADRA1A 967/4885ADRA1B 1241/4885 |
| US-20240368068-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATES | POR, PPOX, ACLY | ADRA1D 2894/4885ADRA1A 2225/4885ADRA1B 2020/4885 |
| US-20230095887-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATE | POR, CYP1B1, CYP1A2 | ADRA1D 2497/4885ADRA1A 2049/4885ADRA1B 1674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.